Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA-Reference-Cited by-同舟云学术

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA

Published:2018-03-16 Issue:3 Volume:13 Page:e0194630
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gale Davina^ORCID,Lawson Andrew R. J.,Howarth Karen,Madi Mikidache,Durham Bradley,Smalley Sarah,Calaway John,Blais Shannon,Jones Greg,Clark James,Dimitrov Peter,Pugh Michelle,Woodhouse Samuel,Epstein Michael,Fernandez-Gonzalez Ana,Whale Alexandra S.,Huggett Jim F.,Foy Carole A.,Jones Gerwyn M.,Raveh-Amit Hadas,Schmitt Karin,Devonshire Alison,Green Emma,Forshew Tim,Plagnol Vincent,Rosenfeld Nitzan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release;M Stroun;Clin Chim Acta,2001

2. Identification of p53 gene mutations in bladder cancers and urine samples;D Sidransky;Science,1991

3. Liquid biopsies come of age: towards implementation of circulating tumour DNA;JC Wan;Nat Rev Cancer,2017

4. Circulating mutant DNA to assess tumor dynamics;F Diehl;Nat Med,2008

5. Analysis of circulating tumor DNA to monitor metastatic breast cancer;SJ Dawson;N Engl J Med,2013

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

2. Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer;Cancer Treatment Reviews;2024-09

3. Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma;Cancers;2024-09-01

4. From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations;Frontiers in Molecular Biosciences;2024-08-06

5. Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring;Aging;2024-07-19